Study Details

Back to Search Results

OSI-774 (Tarceva) in Treating Patients with Stage III or Stage IV Non-Small Cell Lung Cancer

This trial is complete
The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred).

Clinicaltrials.gov ID

The unique identification code given to each clinical study upon registration at ClinicalTrials.gov.
NCT00036647

Astellas Study ID

The unique identification code given by the study sponsor.

BR.21

EudraCT ID

The unique identification code given to each clinical study upon registration at EudraCT (European Union Drug Regulating Authorities Clinical Trials Database).

N/A

Follow Trial

Condition

Non Small Cell Lung Cancer

Phase

These clinical trials are done to confirm that an experimental treatment helps participants who have a specific condition. These clinical trials often compare the experimental treatment to another treatment or, if appropriate, a placebo.

Phase 3

Age

18 Years - N/A

Sex

Female & Male

Product

N/A

Type

A type of clinical study in which participants are assigned to groups that receive one or more intervention/treatment (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.

Interventional

Trial Dates

Nov 2001 - Jan 2004

Masking

Not Available

Enrollment number

731

A randomized placebo controlled study of OSI-774 (erlotinib HCl, Tarceva[TM]) in patients with incurable stage IIIB/IV non-small cell lung cancer who have failed standard therapy for advanced or metastatic disease

Study summary

Study documents

Study Documents, including study results, are available after a study is completed or terminated, according to Astellas Transparency policy.

Get More Information

Would you like more information about clinical trial sites that are recruiting participants for OSI-774 (Tarceva) in Treating Patients with Stage III or Stage IV Non-Small Cell Lung Cancer? Contact us by filling our your information to the right and we’ll respond to you.

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

Locations

Hotel Dieu Health Sciences Hospital

St. Catherines, Canada, L2R 5K3

Group Health Centre

Sault St. Marie, Canada, P6A 2C4

The Royal Victoria Hospital

Barrie, Canada, L4M 6M2

Southlake Regional Health Centre

Newmarket, Canada, L3Y 2P9

Cross Cancer Institute

Edmonton, Canada, T6G 1Z2

Hopital Laval

Ste-Foy, Canada, G1V 4G5

Toronto East General Hospital

Toronto, Canada, M4C 3E7

Princess Margaret Hospital

Toronto, Canada, M5G 2M9

Hopital Notre-Dame du CHUM

Montreal, Canada, H2L 4M1

Toronto-Sunnybrook Reg.Canc.Center

Toronto, Canada, M4N 3M5

Peterborough Regional Health Centre

Peterborough, Canada, K9H 7B6

Northeastern Ontario Regional Cancer Centre

Sudbury, Canada, P3E 5J1

Mount Sinai Hospital

Toronto, Canada, M5G 1X5

Cancer Centre for the Southern Interior

Kelowna, Canada, V1Y 5L3

CancerCare Manitoba (CCMB)

Winnipeg, Canada, R3E 0V9

Tom Baker Cancer Centre

Calgary, Canada, T2N 4N2

Dr.H. Bliss Murphy Cancer Centre

St. John's, Canada, A1B 3V6

BCCA - Vancouver Island

Victoria, Canada, V8R 6V5

Allan Blair Cancer Centre

Regina, Canada, S4T 7T1

QEII Health Sciences Centre

Halifax, Canada, B3H 2Y9

Hamilton Regional Cancer Centre

Hamilton, Canada, L9V 5C2

Kingston Regional Cancer Centre

Kingston, Canada, K7L 5P9

Ottawa Regional Cancer Centre

Ottawa, Canada, K1H 1C4

Credit Valley Hospital

Missisauga, Canada, L5M 2N1

Royal Adelaide Hospital

South Australia, Australia, 5000

Johannesburg Hospital

PARKTOWN, South Africa, 2193

Rosebank Clinic Oncology Unit

Rosebank, South Africa

Oncotherapy Dept, National Hospital

Bloemfontein, South Africa, 9301

Wellington Hospital

Riddiford Street, New Zealand

Institution: Clinica Las Condes

Santiago, Chile

Hopital Du Sacre - Coeur De Montreal

Montreal, Canada, H4J 1C5

National Cancer Centre - Singapore

Singapore, Singapore, 169610

The Royal Melbourne Hospital

Parkville, Australia, 3050

Oncology Institute Bucharest

Bucharest, Romania

Clinical County Hospital

Sibiu, Romania, 2400

Peter MacCallum Cancer Institute

Victoria, Australia, 3002

Canberra Hospital- Australia

Woden, Australia, 2605

Greenlane Hospital - New Zealand

Auckland 3, New Zealand

Newcastle Mater Misericordiae Hospital

Waratah, Australia, 2289

Kaplan Medical Center

Rehovot, Israel

Sir Charles Gairdner Hospital

Nedlands, Australia, 6009

Instituto Nacional de Cancerologia

Mexico City, Mexico, 14000

Oncology Institute Ion Chiricuta

Cluj-Napoca, Romania, 3400

Die Wilgers Hospital

Lynnwood, South Africa

Faculdade de Medicina do ABC

Santo Andre, Brazil, 09060-650

Durban Oncology Centre

Westbridge, South Africa, 4091

Eastern Cape Oncology Centre

Port Elizabeth, South Africa, 6000

Hospital Sao Lucas da PUCRS

Porto Alegre, Brazil, 90610-000

Prince of Wales Hospital

Randwick, Australia, 2031

Escola Paulista de Medicina

Sao Paulo, Brazil, 040039-032

Haemek Medical Center

Afula, Israel, 18101

Pramongkutklao Hospital

Phayathai, Thailand, 10400

Instituto Nacional de Cancerologia

Rio De Janeiro, Brazil, 20230-130

Nucleo de Oncologia da Bahia

Salvador, Brazil, 40170-070

Spitalul Universitar

Iasi, Romania, 6600

Hospital Vera Cruz S/A

Belo Horizonte, Brazil, 30190-130

Instituto do Cancer Arnaldo Vieira de Carvalho

Sao Paulo, Brazil, 01224-010

Instituto do Cancer do Ceara

Fortaleza, Brazil, 60430-230

Mary Potter Oncology Centre

Pretoria, South Africa

University of Pretoria

Pretoria, South Africa

National University Hospital

Singapore, Singapore, 119074

Chiangmai University

Chiangmai, Thailand, 50002

Irmandade Santa Casa de Miseicordia de Porto

Porto Alegre, Brazil, 90020-090

Sandton Oncology Centre

Parklands, South Africa, 2121

Austin & Repatriation Medical Centre

Victoria, Australia, 3084

RAMBAM Medical Center

Haifa, Israel

Centro Medico Confidence

Buenos Aires, Argentina, 1642

Southern Medical Day Care Center

Wollongong, Australia, 2500

Rabin Medical Center Beilinson Campus

Petach-Tiqva, Israel, 49100

Hospital Interzonal de Agudos Evita

Buenos Aires, Argentina, B1824

Hospital Churruca Visca

Buenos Aires, Argentina, C1427

Rabin Medical Center Golda Campus

Petach-Tiqva, Israel, 49372

Sheba Medical Center Oncology Day Care

Tel Hashomer, Israel, 52621

Hospital Britanico

Buenos Aires, Argentina, 1280

Sourasky Medical Center Oncology Institute

Tel Aviv, Israel, 64239

Instituto Oncologico Angel Roffo

Capital Federal, Argentina, CP1417

University of Chicago Medical Center

Chicago, United States, 60637

Instituto Alexander fleming

Buenos Aires, Argentina, C1426ANZ

Hospital Italiano

Capital Federal, Argentina

Pamela Youde Nethersole Easter Hospital

Hong Kong, China

Hospital Central Sur de Alta Especialidad, PEMEX

Mexico City, Mexico

Centro Estatal de Cancerologia de Durango

Durango, Mexico

Sahlgrenska University Hospital

Lund, Sweden

Thoraxklinik Heidelberg

Heidelberg, Germany, 69126

Lund University Hospital

Lund, Sweden

Div. of Med Onc. The National Cancer Institute of Thailand

Bangkok, Thailand, 10400

Zentrum fur pheulmologie und Thoraxchirurgie

Grosshansdorf, Germany, 22927

Lungenklinik Hermer

Hermer, Germany, 58675

Queen Mary Hospital

Hong Kong, China

McGill University

Montreal, Canada, H2W 1S6

Asklepios Fachkiniken

Gauting, Germany, 82131

Lungenklinik Heckeshorn

Berlin, Germany, 14109

Sotiria Hospital

Athens, Greece, 115 27

Assaf Harofeh Medical Center

Zerifin, Israel, 70300

Humbar River Regional Hospital

Weston, Canada, M9N 1N8

Western Hospital

Footscray, Australia, 3011

University of Washington

Seattle, United States, 98109

The purpose of this website is to offer education and information to patients and their families and friends, the public, and healthcare professionals about the clinical trial process. In addition, the website will provide specific information about Astellas clinical trials. Please read the complete Astellas Transparency Policy to learn about the clinical trial information available on this website

© ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.

POWERED BY:

Pharma Intelligence logo